Rami Elghandour Sells $2.41M of Arcellx Inc (ACLX) — SEC Form 4, Feb 12, 2024
Open-Market Net Sale · SEC Form 4
−$2,410,740
Equity position changed by -29.2%
Equity Position
92.3K sh
130,404 → 92,339
Equity Change
-29.2%
shares held after vs before
Filing Lag
0 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Rami Elghandour CIK 0001613689 |
Director
CEO
|
Rami Elghandour at Arcellx Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$10,243,267
More from this insider at Arcellx Inc
| 2026-04-28 | Award | — | View |
| 2026-03-05 | Gift/Other | — | View |
| 2026-02-28 | Sell | -$10,243,267 | View |
| 2026-02-14 | Gift/Other | — | View |
| 2026-02-14 | Gift/Other | — | View |
Non-Derivative Securities Transactions
Footnotes (2)
- F1
- Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units. Show more
- F2
- The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices that were not available from the broker at the time of filing. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Show more
Remarks
President, CEO and Chairman of the Board
Show moreRelated filings at Arcellx Inc
Institutional Holders
13F holders · Jun 30, 2026
2
institutional managers reporting a position
Largest by reported value
- Deka Bank Deutsche Girozentrale $3.43M
- Ifp Advisors, Inc $1.5K
5%+ Holders · 13D/G
2 filers
-
Gilead Sciences, Inc. 100.0%
-
Black Rock, Inc. 6.4%
Other insiders at Arcellx Inc
GET /v1/forms/4/0001415889-24-003447
API docs
View Original SEC Filing